To examine whether CDK6 functionally drives self-renewal and tumor formation, we manipulated CDK6 expression in HCC cells using lentiviral-based knockdown and the CRISPR/dCas9-VP64-p65-Rta gene activation system (Dharmacon). The gene discussed is CDK6; the disease is hepatocellular carcinoma.